ClinicalTrialsFinder

Pevifoscorvir Sodium (ALG-000184) Clinical Trials

2 recruitingDrug
Phase 12

Showing 1–2 of 2 trials

Recruiting
Phase 1

Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function

Chronic Hepatitis B Infection
Aligos Therapeutics30 enrolled2 locationsNCT07342881
Recruiting
Phase 1

Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Chronic Hepaititis B Infections
Aligos Therapeutics16 enrolled1 locationNCT07342868